Posted in Regulatory Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy April 21, 2026 Pharmaceutical Technology Pfizer and Astellas have received FDA acceptance for priority review of their sBLA for perioperative Padcev combined with Keytruda for MIBC. RegulatoryOncologyRead full story